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Background: Panax ginseng is a famous traditional medicine in Korea for its beneficial effect on obesity, cardiac and liver
associated diseases. The aim of this study was to investigate the metabolite in Panax ginseng (P. ginseng, Aralicaceae)
berries depending on the ripen stages and evaluate its potential inhibition on adipocyte differentiation in 3 T3-L1 cells.
Methods: Different ripening stage samples of P. ginseng berry were analyzed through global metabolite profiling by
NMR spectroscopy. Lipid accumulation in the cells was analyzed by Oil Red O staining.
Results: The PLS-DA clearly distinguished P. ginseng berry extract (PGBE) according to the partial ripe (PR), ripe(R) and
fully ripe (FR) stage. Lipid accumulation of PGBE was examined by measuring triglyceride content and Oil-Red O staining.
These results suggested that the FR stage of PGBE decrease in lipid accumulation during adipocyte differentiation and
the amount of threonine, asparagine, fumarate, tyraine, tyrosine, and phenylalanine increased with longer ripening of
ginseng berries.
Conclusion: Metabolite profiling of P. ginseng was identified by 1H NMR spectra. P. ginseng extract efficiently inhibits
adipogenesis in 3 T3-L1 adipocytes concluded that the P. ginseng has the antiobesity properties.
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Obesity is a risk factor for major metabolic disease in-
cluding type 2 diabetes, atherosclerosis, hyperlipidemia
and hypertension and multifactorial syndrome in human
[1,2]. It is an abnormal condition in which the lipids are
accumulated in adipose tissues and various kinds of
adipokine [3]. Panax ginseng is a perennial plant that
has been used as a tonic and for the treatment of various
diseases [4-8]. P. ginseng root is normally harvested
between the fourth and sixth year of growth. The multiple
active constituents such as ginsenosides, polysaccharides,
peptides, polyacetylenic alcohols and fatty acids are identi-
fied in the P. ginseng root [9]. On the other hand, P.
ginseng berry easily be harvested several times after the
third year of growth [10]. Quan et al. [11] reported that* Correspondence: kyo9128@korea.kr
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unless otherwise stated.ginsenoside Re (groups, namely protopanaxatriol-type
saponin from ginseng) lowers blood glucose and lipid
in high-fat diet fed mice. However, effects on adipocyte
differentiation in 3 T3-L1 cells on PGBE have not yet
been reported. The chemical composition and biological
activities of the P. ginseng berry may differ according to
the maturation stage. We have looked for lipid accumu-
lation in adipocyte inhibitory plants using PGBE as an
in vitro assay system. During the course of screening,
the water extract of P. ginseng berry was significantly
inhibited this activity. The metabolic profiling can be
useful for quantifying a group of related compounds.
There are few previous studies about profiling metabolic
compounds of ginseng by using NMR [12,13]. However, no
study reported in differences of the metabolic compounds
among different maturation stages in ginseng fruits. The
aim of this study was to classify the ginseng berry (Panax
ginseng) extract using 1H NMR spectroscopy and evaluates
its inhibition of lipid accumulation in 3 T3-L1 cells.d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Representative total 1H NMR spectra (600 MHz) of the P. ginseng berry extract analyzed with direct D2O extraction.
Table 1 Assignment of 1H NMR spectral peaks obtained
from P. ginseng berry extract analyzed by using D2O
solvent. S: singlet, d: doublet, t: triplet, m: multiplet,
dd: doublet of doublet
No Compounds Chemical shift (δ), Peak multiplicity,
J value (Hz)
1 Leucine 0.95 (d, J = 6.0)
2 Valine 0.99 (d, J = 5.4), 1.03 (d, J = 7.1)
3 Threonine 1.32(d, J = 6.9)
4 Alanine 1.47 (d, J = 7.3)
5 Glutamate 2.10-2.16(m), 2.29 (t, J = 7.4, 2.48-2.48 (m)
6 Glutamine 2.10-2.16 (m), 2.40-2.48 (m)
7 Asparagine 2.85 (dd, J = 16.9, 7.7), 2.94 (dd, J = 16.9, 4.2)
8 2-Oxoglutaric acid 3.00 (t, J = 7.2)
9 Malonate 3.19 (s)
10 Glucose 3.21-3.25(m), 3.36-3.43 (m), 3.43-3.54 (m),
3.67-3.82 (m), 3.89 (dd, J = 11.9, 1.6), 4.63
(d, J = 8.0), 5.22 (d, J = 3.8)
11 Fumarate 6.51 (s)
12 Tyramine, 6.89 (d, J = 8.5), 7.18 (d, J = 8.3)
13 Tyrosine 6.89 (d, J = 8.5), 7.18 (d, J = 8.3)
14 Phenylalanine 7.31 (d, J = 7.8), 7.36 (t, J = 7.3), 7.41 (t, J = 7.6)
15 Formate 8.44 (s)
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Plant material
Three steps berries of five year-old P. ginseng were
obtained from a local farm in Eumseong province (GPS
N 36° 56’ 34”, E 127° 45’ 14”), Republic of Korea. The
collected plants were identified by the botanist in Ginseng
Research Institiute, Daegu, South Korea. The collected
samples were stored in the Medicinal Crop Research Insti-
tute, NIHHS, RDA, with voucher number MCRI-241.
Three periods were June 8th, 2012 (12ea), June 18th, 2012
(10ea), and July 16th, 2012 (8ea), respectively. The collected
P. ginsengs were classified into three major categories
according to their stage of maturation: ripe (R), and fully
ripe (FR). The PGBE was freeze-dried and then stored
at −70°C before analysis. Voucher specimens were de-
posited at the Department of Medicinal Crop Research,
Rural Development Administration in Republic of Korea
(RDAPGBE 201201–201230).
Sample preparation for 1H NMR
PGBE were extracted by adding 1 mL of 100% D2O to
30 mg of powdered P. ginseng berries in a micro tube,
vortexed for 1 min, and sonicated for 5 min. The materials
were then centrifuged at 14000 × rpm for 10 min. KH2PO4
was added as a buffering agent to 100 mL of D2O contain-
ing 0.05% 3-(trimethylsilyl)-propionic-2,2,3,3-d4 acid,
sodium salt (TSP) as an internal standard for D2O. The
pH of the D2O used for NMR measurements was adjusted
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ferred to a 5 mm NMR tube.
Data reduction and processing
MestReNova (version 6.0.4) was used to obtain the NMR
spectra, which were all automatically binning using
Chenomx (version 5.1) software. The spectral 1H NMR
region from δ = 0.56 to δ = 10.00 was segmented into
regions with widths of 0.04 ppm, giving 232 integrated
regions in each NMR spectrum.
Cell culture
3 T3-L1 preadipocyte purchased from ATCC were
cultured in 24 well plate at a density of 3×104 cells/well.
In DMEM containing 10% FBS, 2 mM glutamine, 20 mM
Hepes, 50U/ml penicillin, and 50 mg/ml streptomycinFigure 2 PLS-DA-derived score plot (a) and loading plot (PLS compon
analyzed with D2O direct extraction. (green circle symbol): PR, (blue circ
4: alanine, 5: glutamate, 6: glutamine, 7: asparagines, 8: 2-oxoglutaric acid, 9
phenylalanine, 15: formate.sulfate. After 100% confluency, cells were cultured with
differentiation medium (DMEM with 10% FBS, 0.5 mM
IBMX, 2 mM DEX and 1.7 mM INS). After 48 h of stimu-
lation, cells were cultured in DMEM supplemented with
10% FBS with/without PGBE and changed every two days
up to 8 days.
Oil Red O staining
Lipid accumulation of PGBE was examined by measur-
ing triglyceride content using Oil-Red O staining. For
Oil Red O staining, cells were washed gently with PBS
twice, fixed with 3.7% fresh formaldehyde in PBS for 1 h
at room temperature and stained with filtered Oil Red O
solution (60% isopropanol and 40% water) for at least
1 h. After staining of lipid droplets with Red, the Oil
Red O staining solution was removed and the platesent 1: b and PLS component 2: c) of P. ginseng berry extract
le symbol): R, (red circle symbol): FR . 1: leucine, 2:valine, 3: threonine,
: malonate, 10: glucose, 11: fumarate, 12: tyramine, 13: tyrosine, 14:
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on an Olympus microscope (Tokyo, Japan). Finally, the
dye retained in the cells was eluted with isopropanol and
quantified by measuring the optical absorbance at 500 nm.Multivariate statistics analysis
Principal component analysis (PCA) was performed using
mean Pareto-scaled data obtained from aqueous solvent
system. Then, partial least squares-discriminant analysis
(PLS-DA) was also performed, which can yield a clearer
differentiation of each class and enable a less complicated
investigation of marker compoundsStatistical analysis
Unless otherwise specified, all data are expressed as the
mean ± standard error (SE) from triplicate experiments.
One-way ANOVA (Scheffe test or student t test) was used
for multiple comparisons using the Statistical Package for
the Social Sciences (SPSS) program (version 16.0) (SPSS,Figure 3 Effects P. ginseng berry extract on Oil Red O staining in cult
of P. ginseng berry extract. (a) Effects of P. ginseng berry extract on fat dro
examined with a light microscope; (b) Relative lipid content by quantificati
(n =5). * indicates *** p <0.001 compared with control (expressed by t-testInc., Chicago, IL, USA). Values of p < 0.05 were considered
statistically significant.
Results and discussion
Figure 1 shows a representative NMR spectrum of the
D2O extracts from the PGBE at the mature stage. As
described in Table 1, the signals were assigned based on
comparisons with the database of the Chenomx NMR
software suite: amino acid such as leucine, valine, threo-
nine, alanine, glutamate, glutamine, asparagines, malonate,
tyramine, tyrosine, and phenylalanine; organic acid such
as 2-oxoglutarate, fumarate, and formate; sugars such as
glucose.
PCA could clearly separate the maturation of ginseng
berries based on the score plots (data not shown). PLS-
DA was applied to the 1H NMR spectral data of P. ginseng
berries according to three different maturation periods.
The different maturation of the ginseng fruit samples were
clearly distinguished based upon the PLS-DA-derived
score plots (Figure 2a). Depending on the maturation ofured 3 T3-L1 adipocytes. 3 T3-L1 cells were treated with 100 μg/ml
plet formation in 3 T3-L1 cells. It was stained with Oil Red O dye and
on method of Oil Red O staining. Data are presented as average ± SD
).
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tive direction of PC1. Loading plot analysis was performed
to investigate the contributing metabolites for separating
each PGBE from the score plots. As shown in Figure 2b,
the levels of leucine, valine, alanine, glutamate, glutamine,
2-oxoglutarate, malonate, and glucose were higher in the
PR stage samples than the FR berries. In addition, threonin,
asparagines, fumarate, tyramine, tyrosine, and phenylalan-
ine were higher in the FR berries than the PR ones. The
levels of leucine, valine, threonin, alanine, asparagines, 2-
oxoglutarate, malonate, phenylalanine, and formate were
higher in the ripening fruits (Figure 2c) than other stages.
3 T3-L1 cells of the adipocyte morphology increase the
synthesis and accumulation of triglycerides and acquire
the signet ring appearance of adipose cells [14]. 3 T3-L1
cells are extensively used to study adipogenesis [15]. For
this reason, we chose these cells for research to identity
the feasibility of PGBE as a possible new anti-obesity
herbal agent. This observation was further supported with
the quantitative analysis of neutral lipid content by meas-
uring the absorbance at 500 nm. 3 T3-L1 cells were
treated with various maturation stage of PGBE. After
8 days, intracellular lipid accumulation was examined with
Oil red O staining for lipid droplets as an indicator of
the degree of adipogenesis. Figure 3a showed that the
cell size was bigger and the intracellular fat drops were
comparatively more in 3 T3-L1 cells. And comparatively
adipogenesis and cell viability were decreased 100ug/ml
treated group. In addition, the lipid accumulation rate was
significantly reduced with PGBE treatment compared with
the control; the decrease was maturation stage dependent
(p <0.001); accumulation was about 67%, 46%, and 33% at
PR, R, and FR by aqueous extraction concentration in
Figure 3b.
In previous, many studies have reported the anti-obesity
effects in various medicinal plants, such as Nigella sativa
[16], Camellia sinensis [17], Hibiscus sabdariffa [18], Psyl-
lium fibre [19], and Lycium barbarum [20]. Dey et al. [21]
demonstrated the anti-obesity effect in Asian ginseng
berry extract, and Attele et al. [22] also showed the anti-
hyperglycemic effect in ginsenoside Re. According to Kim
et al. [23], the group of people whom the black soybean
peptide had been taken showed the decreased body mass
and fat. The scientific study shows that natural products
contain a large variety of components that possess lipid
inhibition activity. Especially, a variety of herbs from
plants have been used as traditional natural medicines for
cure many kinds of diseases or restore to health. In
particular, various oriental medicinal herbs are reported to
have biological activity [24,25].
In this study, it was confirmed that the amount of
phenylalanine is higher in FR stage of P. ginseng berries,
thus expecting to lower the obesity. Further in vivo research
and clinical trials are still need to clarify the efficacy, safety,and precise molecular mechanisms of the anti-obesity
effects of PGBE.
Conclusion
In conclusion, this is the first study regarding metabolic
profiling of PGBE using D2O solvent. Moreover, multi-
parameter pattern recognition analysis established 1H
NMR spectra of PGBE. And PGBE efficiently inhibits
adipogenesis in 3 T3-L1 adipocytes as indicated by sig-
nificant reduction lipid accumulation. It is predicted that
P. ginseng berry extract may apparently inhibit the
adipogenic differentiation and lipid accumulation in the
cells through the activation of various adipogenic regulatory
genes such as peroxisome proliferator-activated receptor
(PPARγ) and CCAAT element binding protein (C/EBP-α).
Further the mechanism underlying the anti-adipogenic
activity of P. ginseng berry extract has to be studied in the
future.
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